Skip to main content

Full text of "USPTO Patents Application 09804625"

See other formats


PATENT 
Customer No. 22,852 
Attorney Docket No. 08702.0039-02000 



AMENDMENTS TO THE CLAIMS: 

This listing of claims will replace all prior versions and listings of claims in the 
application: 

1-23. (Cancelled) 

24. (Currently amended): An isolated polynucleotide comprising [ DNA 
soquonco solootod from tho group oons i et i ng of ]: 

(a) nucleotides 1 202 through 1 543 of Figure 2; 

(b) nucleotide 1 252 through 1 543 of Figure 2; 

(c) nucleotides encoding amino acids 283 through 396 of Figure 2; or 

(d) nucleotides encoding amino acids 299 through 396 of Figure 2; 

(e) naturally occurring allelic variants of (a) through (d). 

25. (Currently amended): An isolated polynucleotide [DNA soquonco ] 
comprising nucleotides 1202 through 1543 of Figure 2. 

26. (Currently amended): An isolated polynucleotide [DNA soquonco ] 
comprising nucleotides 1252 through 1543 of Figure 2. 

27-28. (Cancelled) 

29. (Currently amended): An isolated polynucleotide [DNA soquonco ] 
comprising nucleotides encoding amino acids 283 through 396 of Figure 2. 

30. (Currently amended): An isolated polynucleotide [ DNA soquonco ] 
comprising nucleotides encoding amino acids 299 through 396 of Figure 2. 

31-32. (Cancelled) 



-3- 



PATENT 
Customer No. 22,852 
Attorney Docket No. 08702.0039-02000 



33. (Currently amended): An isolated polynucleotide comprising a 
polynucleotide [ DNA soquonco ] that hybridizes under stringent conditions to a [SNA] 
polynucleotide complementary to a polynucleotide of claim 24 [ soquonco compris i ng 
nucloot i dos 1252 to 1543 of F i gure 2 undor str i ngent hybr i d i zat i on cond i t i ons ], wherein 
said isolated polynucleotide [ DNA soquonco ] encodes a [ bono morphogonotic ] protein 
characterized by the ability to induce the formation of cartilage and/or bone tissue. 

34. (Cancelled) 

35. (Currently amended): A vector comprising a polynucleotide [ DNA 
s e qu e nce ] of claim 24 in operative association with an expression control sequence 
therefore. 

36. (Currently amended): A vector comprising a polynucleotide [ DNA 
soquonco ] of claim 33 in operative association with an expression control sequence 
therefore. 

37. (Cancelled) 

38. (Previously presented): A host cell transformed with a vector of claim 35. 

39. (Previously presented): A host cell transformed with a vector of claim 36. 

40. (Cancelled) 

41 . (Currently amended): An isolated polynucleotide [ DNA s e qu e nc e] 
selected from the group consisting of ATCC deposits 40345 and 40342. 

42. (Currently amended): A method for producing a [BMP] bone 
morphooenetic protein -2 protein A said method comprising the steps of: 



-4- 



PATENT 
Customer No. 22,852 
Attorney Docket No. 08702.0039-02000 



a) culturing a host cell transformed with a polynucleotide [DNA 
coquonco ] of claim 33, and 

b) recovering said [BMP] bone morphoaenetic protein -2 protein. 
43-49. (Cancelled) 



-5-